At TD2, we are revolutionizing oncology research through an integrated ecosystem that brings together preclinical services, advanced flow cytometry, robust regulatory support, an extensive …

At TD2 Oncology, we provide tailored regulatory strategies that accelerate your drug development journey. With a comprehensive understanding of the complexities of the global regulatory …

At the core of TD2 is our comprehensive oncology ecosystem, a uniquely integrated approach connecting preclinical, clinical, and regulatory phases. We prioritize scientific innovation and …

TD2 Oncology accelerates preclinical drug development with a robust suite of in vivo and in vitro tumor model systems and advanced bioanalytical services, designed to generate clinically …

TD2 specializes in navigating the unique challenges of ADC clinical trials. From optimizing trial design to ensuring precise bioanalytics and robust safety monitoring, we provide the …

Translational Drug Development (TD2)—an oncology-specialty CRO that guides medicines through the preclinical, regulatory and clinical trial processes—conducted preclinical trials over …

There’s countless opportunities to learn and grow at TD2. From designing the eCRFs, creating therapeutic area standards, hands-on programming, exploring existing platforms and adapting …

Work with a team who believes in your research as much as you do.

At TD2 Oncology, we provide comprehensive clinical research solutions tailored specifically for oncology. From trial design and feasibility through site management, data analysis, and final …

Sep 4, 2024 · TD2 will be highlighting their expanded capabilities at the upcoming European Society of Medical Oncologists (ESMO) Congress September 13-16 in Barcelona, Spain. Their …